Rudower Straße 48
12351 Berlin
Phone:
030-130-10
Fax:
030-13014-3278
Mail:
ed.setnaviv@ofni
Versorgung im MVZ Adlershof
Quantity performed | 32 |
Exception? | No exception |
Quantity performed | 30 |
Exception? | No exception |
Quantity performed | 41 |
Exception? | No exception |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 32 |
Quantity forecast year: | 38 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 30 |
Quantity forecast year: | 35 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 41 |
Quantity forecast year: | 49 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
Overall result forecast presentation: | yes |
Quantity performed reporting year: | 183 |
Quantity forecast year: | 169 |
Examination by state associations? | yes |
Exemption? | yes |
Result of the examination by the federal state authorities? | yes |
Transitional arrangement? | no |
No. | Explanation |
---|---|
CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
CQ05 | Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1 |
CQ26 | Decision on measures for quality assurance of targeted lung denervation by catheter ablation in chronic obstructive pulmonary disease |
CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
Number | Group |
---|---|
283 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
168 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
133 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.
https://www.vivantes.de/klinikum-neukoelln/kinderschutzambulanz
regelmäßige interne und externe Mitarbeiter*innen- Schulungen; Treffen der interprofessionellen Team Kinderschutzgruppe
Education
erweitertes Führungszeugnis
4 Augen Prinzip bei Untersuchungen mit gegengeschlechtlicher Konstellation von untersuchender Person und zu untersuchendem Kind möglich, zusätzlich zur Anwesenheit der Eltern;
Limitierung des Zugangs zu den Stationen, teilweise Video gestützte Eingänge
Erfassung der Fälle und ggf. Nachbesprechung im interprofessionellen Team (Kinderschutzgruppe)
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
Electronic documentation of the administration of drugs
FL01 - Lectureships / teaching posts at colleges and universities
FL02 - Lectureships / teaching posts at universities of applied sciences
FL03 - Student training (clinical traineeship / internship year)
FL04 - Project-related cooperation with colleges and universities
nur an Phase-II-Studien
FL06 - Participation in multi-centre phase III/IV studies
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
FL08 - Editors of scientific journals/textbooks
FL09 - Doctoral supervision
seit April 2022
seit April 2021, seit 2023 neue Bundesgesetzgebung in Umsetzung
ab 2022, neue Bundesgesetzgebung umgesetzt
seit Oktober 2022
seit Oktober 2021, Studium mit der Universität der Charité Berlin
seit Februar 2023, neue Bundesgesetzgebung umgesetzt
ab 2022, Bundesgesetzgebung umgesetzt
seit Oktober 2021
seit 2020, Pflegefachassistenz seit November 2022, Umsetzung der neuen Ausbildung nach Landesgesetzgebung
Kooperationspartner für die ASH
Eveline Heidenreich
Patientenfürsprecherin Psychiatrie
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-3413
Mail:
ed.nilreb@2-knk.viv-ftap
Kathrin Schuhmann
Patientenfürsprecherin Somatik
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-3105
Mail:
ed.nilreb@1-knk.viv-ftap
J. Bauerfeld | P. Sperling
Qualitätsmanager*innen
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2483
Mail:
ed.setnaviv@knk.mq
C. Mixa | P. Sperling
Qualitätsmanagement
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2483
Mail:
ed.setnaviv@knk.mq
Dr. J. Danckert
GF Klinikmanagement
Rudower Straße 48
12351 Berlin
Phone:
030
-130-10
Mail:
ed.setnaviv@ofni
Prof. Dr. Reinhold A. Laun
Ärztlicher Direktor
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2121
Mail:
ed.setnaviv@nual.dlohnier
PD Dr. Mario Müller
Ärztlicher Direktor
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2061
Mail:
ed.setnaviv@relleum.oiram
Dr. Ulrike Zuther
Leitung Vivantes Apotheke Süd
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2560
Mail:
ed.setnaviv@rehtuz.ekirlu
Ariane Schulze
Leitung Sozialdienst-Somatik
Rudower Straße 48
12351 Berlin
Phone:
030
-13019-2580
Mail:
ed.setnaviv@ezluhcs.enaira
Phone:
030-130-10
Fax:
030-13014-3278
Mail:
ed.setnaviv@ofni
Peggy Dubois
Pflegedirektorin
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2350
Mail:
ed.setnaviv@siobud.yggep
Detlev Corsepius
Geschäftsführender Direktor
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2100
Mail:
ed.setnaviv@knk.dg-tairaterkes
Thomas Wüstner
Geschäftsführender Direktor ab 01.01.2022
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2100
Mail:
ed.setnaviv@knk.dg-tairaterkes
K. Runck
Abteilungsleitung Patientensicherheit und Qualität
Rudower Straße 48
12351 Berlin
Phone:
030
-13011-1405
Mail:
ed.setnaviv@tnemeganamsteatilauq
Prof. Dr. Reinhold-Alexander Laun
Ärztlicher Direktor
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2121
Mail:
ed.setnaviv@nual.adlohnier
PD Dr. med. Mario Müller
Ärztlicher Direktor ab 01.01.2022
Rudower Straße 48
12351 Berlin
Phone:
030
-13014-2061
Mail:
ed.setnaviv@relleum.oiram
IK: 261101878
Location number: 773183000
Old location number: 773183000